Related Experiment Video
Updated: Jul 10, 2026

10:10
In Vivo Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints
Published on: December 9, 2025
Collagen-induced arthritis in mice
1Kennedy Institute of Rheumatology Division, Imperial College London, UK.
Methods in Molecular Medicine
|November 7, 2007
Summary
Collagen-induced arthritis in mice models rheumatoid arthritis, showing T- and B-cell responses and joint damage. Blocking key inflammatory cytokines effectively reduces disease severity in this arthritis model.
Area of Science:
- Immunology
- Rheumatology
- Animal Models
Background:
- Collagen-induced arthritis (CIA) in mice is a standard model for studying rheumatoid arthritis (RA) pathogenesis.
- Disease susceptibility is linked to major histocompatibility complex class II genes.
- CIA mimics key pathological features of human RA, including synovitis and cartilage degradation.
Purpose of the Study:
- To investigate the pathogenesis of collagen-induced arthritis.
- To validate therapeutic targets for human rheumatoid arthritis.
- To analyze the role of inflammatory cytokines in CIA.
Main Methods:
- Immunization of mice with type II collagen in complete Freund's adjuvant.
- Assessment of T-cell and B-cell responses to type II collagen.
- Histopathological analysis of arthritic joints.
- Evaluation of cytokine expression (e.g., TNF-α, IL-1β).
Main Results:
- Arthritis developed approximately 3 weeks post-immunization.
- Strong T- and B-cell responses to type II collagen were observed.
- Pathological features included synovitis, pannus formation, cartilage degradation, bone erosion, and fibrosis.
- High expression of proinflammatory cytokines like tumor necrosis factor-alpha and interleukin-1beta in affected joints.
Conclusions:
- Collagen-induced arthritis is a robust model for rheumatoid arthritis research.
- Blockade of key proinflammatory cytokines (TNF-α, IL-1β) effectively ameliorates disease severity.
- This highlights the therapeutic potential of targeting these cytokines in human RA.

